Sirolimus tolerability in a kidney transplant recipient with acute intermittent porphyria [4]

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 1147-

  El Haggan, Wael ^a   Lobbedez, Thierry ^a   Ryckelynck, Jean Philippe ^a   de Ligny, Bruno Hurault ^a  

^a CHU Clemenceau   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HEME; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PORPHOBILINOGEN DEAMINASE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADULT; AUTOSOMAL DOMINANT DISORDER; CADAVER DONOR; CASE REPORT; CLINICAL FEATURE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME DEFICIENCY; FOLLOW UP; HEME SYNTHESIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; MALE; NEPHROTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; GENETICS; IMMUNOLOGY; MIDDLE AGED;

CASE REPORT; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; PORPHYRIA, ACUTE INTERMITTENT; SIROLIMUS; HUMANS; MIDDLE AGED;

EID: 0036597952     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Diagnosis and management of porphyria
2. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria
3. A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function
4. Rapamycin in transplantation: A review of the evidence